Transparency Market Research
Toxicology Drug Testing Market Revenue to Cross USD 55.9 billion by 2031, Growing at a CAGR of 5.5% Says Transparency Market Research
August 28, 2023 04:17 ET | Transparency Market Research
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global toxicology drug testing market is projected to flourish at a CAGR of 5.5% from...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
October 04, 2021 16:05 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN
March 09, 2021 08:33 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., March 09, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of...
Inotiv_Logo_CMYK.png
I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Toxicology to Drive Growth of Expanding Toxicology Business
August 11, 2020 08:33 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of...
basi +seventhwave.jpg
BASi Continues Revenue Growth in Third Quarter of Fiscal 2019
August 14, 2019 08:33 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the three and nine...
Cube_Raturn_No_Cage
Researchers Generate Better Data with BASi’s Redesigned Raturn™
May 21, 2019 08:53 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., May 21, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the launch of the Company’s redesigned Raturn™, a...
Certis Logo.png
Certis Oncology Partners With Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services
August 13, 2018 15:30 ET | Certis Oncology Solutions, Inc.
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an...
eilber
Certis Oncology Announces CLIA Certification for High-Complexity Testing
July 16, 2018 08:00 ET | Certis Oncology Solutions, Inc.
SAN DIEGO, July 16, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions, Inc., a new precision medicine company focused on individualized patient care, today announced that it has received its CLIA...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Announces Third and Final Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo
July 12, 2018 11:59 ET | Alliance for Regenerative Medicine
WASHINGTON, D.C., July 12, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, “Moving...
Earth Science Tech,
Earth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical Patents
November 14, 2017 08:00 ET | Earth Science Tech, Inc.
Doral, Nov. 14, 2017 (GLOBE NEWSWIRE) --  Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of industrial hemp...